Lean biomanufacturing : (Record no. 1792)

MARC details
000 -LEADER
fixed length control field 04534cam a22005417i 4500
001 - CONTROL NUMBER
control field 17692510
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210930191537.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130410s2013 enka b 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2013937641
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 101619755
Source DNLM
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 016073421
Source Uk
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781907568787 (print)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1907568786 (print)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781908818409 (online)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)ocn745979945
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
Description conventions rda
Modifying agency BTCTA
-- YDXCP
-- UKMGB
-- CDX
-- EYM
-- UUM
-- BDX
-- OCLCO
-- OCLCF
-- U3G
-- VRC
-- N5L
-- DLC
042 ## - AUTHENTICATION CODE
Authentication code nlmcopyc
-- lccopycat
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number HD9665.5
Item number .S58 2013
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number 2013 J-232
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 55
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1/900685
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Smart, Nigel J.,
Relator term author.
245 10 - TITLE STATEMENT
Title Lean biomanufacturing :
Remainder of title creating value through innovative bioprocessing approaches /
Statement of responsibility, etc. Nigel J. Smart.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Oxford ;
-- Philadelphia :
Name of producer, publisher, distributor, manufacturer Woodhead Publishing,
Date of production, publication, distribution, manufacture, or copyright notice 2013.
300 ## - PHYSICAL DESCRIPTION
Extent xxvii, 355 pages :
Other physical details illustrations ;
Dimensions 25 cm.
336 ## - CONTENT TYPE
Content type term text
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Woodhead Publishing series in biomedicine,
International Standard Serial Number 2050-0289 ;
Volume/sequential designation number 37
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note 1. An introduction to Lean biomanufacturing -- 2. Lean technologies/methods to be applied to biomanufacturing -- 3. Creation, execution and implementation of the Transition Plan -- 4. Issues and problems for the biopharmaceutical industry that make the situation challenging -- 5. Developing a Lean approach to biopharmaceutical processes -- 6. The contribution of simulation models in the development of Lean biopharmaceutical processes -- 7. Integration of biomanufacturing with Lean laboratory operations -- 8. Lean compliance and considerations connected with enabling Lean manufacturing -- 9. Ready to use technologies and their role in Lean biomanufacturing.
520 ## - SUMMARY, ETC.
Summary, etc. With decreasing profit margins, increasing cost pressures, growing regulatory compliance concerns, mounting pressure from generic drugs and increasing anxiety about the future of healthcare reimbursement, pharmaceutical manufacturers are now forced to re-examine and re-assess the way they have been doing things. In order to sustain profitability, these companies are looking to reduce waste (of all kinds), improve efficiency and increase productivity. Many of them are taking a closer look at lean manufacturing as a way to achieve these goals. Lean biomanufacturing re-visits lean principles and then applies them sympathetically - in a highly practical approach - to the specific needs of pharmaceutical processes, which present significantly different challenges to more mainstream manufacturing processes. A major goal of the book is to highlight those problems and issues that appear more specific or unique to biopharmaceutical manufacturing situations and to provide some insights into what challenges are the important ones to solve and what techniques, tools and mechanisms to employ to be successful. Following an introduction to lean biomanufacturing, the book goes on to discuss lean technologies and methods applied in biomanufacturing. Later chapters cover the creation and implementation of the Transition Plan, issues facing the biopharmaceutical industry, creating a lean approach towards biopharmaceutical processes and the contribution of simulation models in developing these processes. The final chapter covers examples of new technology innovations which help facilitate lean biomanufacturing. A focus on the issues associated with the application of lean principles to biomanufacturingPractical examples of factors which can affect biopharmaceutical processesCoverage of key factors which require integration to run an efficient biopharmaceutical process.--
Assigning source Source other than Library of Congress.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical industry.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Research.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Prices.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical Preparations.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biopharmaceutics.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biotechnology
General subdivision methods.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Prices.
Source of heading or term fast
Authority record control number or standard number (OCoLC)fst00898879
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Research.
Source of heading or term fast
Authority record control number or standard number (OCoLC)fst00898894
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical industry.
Source of heading or term fast
Authority record control number or standard number (OCoLC)fst01060129
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Woodhead Publishing series in biomedicine ;
Volume/sequential designation no. 37.
International Standard Serial Number 2050-0289
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a 7
b cbc
c copycat
d 2
e epcn
f 20
g y-gencatlg
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Books
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    Library of Congress Classification     Kwara State University Library Kwara State University Library   2016-08-15   HD9665 .5.S62 2013 014977-02 2016-08-15 2016-08-15 Books
    Library of Congress Classification     Kwara State University Library Kwara State University Library   2016-08-15   HD9665 .5.S62 2013 014977-03 2016-08-15 2016-08-15 Books
    Library of Congress Classification     Kwara State University Library Kwara State University Library   2016-08-15   HD9665 .5.S62 2013 014977-04 2016-08-15 2016-08-15 Books